93431-20-0

Upstream product

• 95207-71-9 3-nitrocinnamylidenemalonic acid 
• 95207-72-0 4-(3-aminophenyl)butane-1,1-dioic acid 
• 99-61-6 3-nitro-benzaldehyde 
• 90991-26-7 5-(3-nitrophenyl)-5-oxopentanoic acid 
• 108-24-7 acetic anhydride 
• 93188-08-0 4-<3-Acetamino-benzoyl>-buttersaeure 

Downstream Products

• 95207-74-2 2-(N-acetyl)amino-6,7,8,9-tetrahydrobenzo-cyclohepten-5-one 
• 3470-55-1 2-amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one 
• 3470-51-7 2-hydroxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one 

Relevant academic research and scientific papers

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

HMG-CoA reductase inhibitors

Compounds are provided of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and trea

Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same

The subject of the invention is tricyclic derivatives of pyrazolecarboxylic acid of formula: in which R1 represents a C3-C15 carboxyl radical or an NR2R3 group. The invention also relates to the method for preparing the compounds of formula (I), pharmaceutical compositions containing them. The compounds of formula (I) are active on cannabinoid CB1 receptors.

Tricyclic dihydropyridazinones and pharmaceutical compositions containing them

The tricyclic dihydropyridazinone derivatives having formula I STR1 are endowed with interesting hypotensive, vasodilating, antiaggregant, antithrombotic and cytoprotective properties and are therefore useful in human or veterinary medicine.

The Synthesis and Photochemical Behaviour of Some Annelated Tropones

The synthesis of 2-methoxy- (12), 2-methoxy-6-bromo- (13), 1-methoxy-4-methyl- (22), 3-amino (33), 3-amino-2,4-dibromo- (35), and 3-methoxy-benzotropone (36) is reported; on irradiation of these and other benzotropones, the presence of an electron-donatin